| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcitriol | 51 | 2013 | 173 | 2.920 |
Why?
|
| Calcium | 65 | 2013 | 1175 | 2.130 |
Why?
|
| Bone Density | 21 | 2014 | 209 | 1.570 |
Why?
|
| Receptors, Calcitriol | 15 | 2016 | 130 | 1.520 |
Why?
|
| Calcium, Dietary | 20 | 2011 | 64 | 1.310 |
Why?
|
| Kidney Calculi | 17 | 2013 | 343 | 1.260 |
Why?
|
| Osteoporosis | 11 | 2016 | 122 | 1.160 |
Why?
|
| Diphosphonates | 5 | 2016 | 36 | 1.150 |
Why?
|
| Osteoporosis, Postmenopausal | 9 | 2014 | 33 | 1.130 |
Why?
|
| Hypercalcemia | 10 | 2013 | 62 | 0.970 |
Why?
|
| Vitamin D | 14 | 2016 | 269 | 0.960 |
Why?
|
| Intestinal Absorption | 26 | 2001 | 124 | 0.960 |
Why?
|
| Parathyroid Hormone | 26 | 2013 | 217 | 0.930 |
Why?
|
| Rats | 61 | 2013 | 4041 | 0.860 |
Why?
|
| Spinal Fractures | 7 | 2016 | 77 | 0.830 |
Why?
|
| Kidney Tubules, Proximal | 11 | 2010 | 60 | 0.830 |
Why?
|
| Kidney | 18 | 2013 | 1147 | 0.810 |
Why?
|
| Duodenum | 13 | 2004 | 103 | 0.760 |
Why?
|
| Femur Neck | 9 | 2014 | 41 | 0.660 |
Why?
|
| Hypercalciuria | 4 | 2013 | 47 | 0.640 |
Why?
|
| Receptors, Calcium-Sensing | 3 | 2013 | 14 | 0.640 |
Why?
|
| Bone and Bones | 10 | 2003 | 269 | 0.580 |
Why?
|
| Calcium Metabolism Disorders | 5 | 2006 | 14 | 0.570 |
Why?
|
| Hip Fractures | 3 | 2008 | 46 | 0.560 |
Why?
|
| Urinary Calculi | 3 | 2005 | 46 | 0.550 |
Why?
|
| Rats, Sprague-Dawley | 18 | 2013 | 1237 | 0.540 |
Why?
|
| Calcium Channel Agonists | 2 | 2005 | 13 | 0.500 |
Why?
|
| Histones | 2 | 2013 | 330 | 0.450 |
Why?
|
| Absorptiometry, Photon | 7 | 2014 | 99 | 0.440 |
Why?
|
| Bone Density Conservation Agents | 2 | 2010 | 46 | 0.430 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2013 | 48 | 0.430 |
Why?
|
| Dietary Supplements | 2 | 2011 | 125 | 0.420 |
Why?
|
| Fractures, Bone | 9 | 2010 | 128 | 0.410 |
Why?
|
| Phosphorus | 21 | 1997 | 117 | 0.410 |
Why?
|
| Lumbar Vertebrae | 7 | 2014 | 151 | 0.410 |
Why?
|
| Intestinal Mucosa | 13 | 2010 | 805 | 0.380 |
Why?
|
| Animals | 68 | 2013 | 27387 | 0.370 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2013 | 382 | 0.360 |
Why?
|
| Protein Kinase C | 5 | 1995 | 268 | 0.360 |
Why?
|
| Male | 84 | 2016 | 42434 | 0.350 |
Why?
|
| Colon | 9 | 2016 | 510 | 0.350 |
Why?
|
| Radiographic Image Enhancement | 4 | 2000 | 463 | 0.350 |
Why?
|
| Kidney Diseases | 3 | 2008 | 319 | 0.320 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 507 | 0.320 |
Why?
|
| DNA Methylation | 1 | 2013 | 657 | 0.310 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2000 | 114 | 0.310 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 6 | 2010 | 10 | 0.310 |
Why?
|
| Monocytes | 3 | 2004 | 218 | 0.300 |
Why?
|
| Cecum | 4 | 2001 | 69 | 0.290 |
Why?
|
| Jaw Diseases | 1 | 2007 | 8 | 0.290 |
Why?
|
| Rats, Inbred Strains | 18 | 1998 | 312 | 0.290 |
Why?
|
| Osteonecrosis | 1 | 2007 | 22 | 0.290 |
Why?
|
| TRPV Cation Channels | 1 | 2006 | 16 | 0.270 |
Why?
|
| Aging | 4 | 2005 | 718 | 0.260 |
Why?
|
| Humans | 77 | 2016 | 89391 | 0.250 |
Why?
|
| Calcium Channels | 1 | 2006 | 182 | 0.250 |
Why?
|
| Female | 54 | 2016 | 46238 | 0.240 |
Why?
|
| Peptide Fragments | 4 | 2013 | 463 | 0.240 |
Why?
|
| Vitamin D Deficiency | 8 | 2011 | 104 | 0.240 |
Why?
|
| Phosphates | 12 | 2013 | 160 | 0.220 |
Why?
|
| Bone Matrix | 1 | 2003 | 19 | 0.220 |
Why?
|
| Calcium Oxalate | 6 | 2013 | 186 | 0.220 |
Why?
|
| In Vitro Techniques | 9 | 2001 | 996 | 0.220 |
Why?
|
| Hydroxycholecalciferols | 8 | 1985 | 13 | 0.210 |
Why?
|
| Calcium Citrate | 1 | 2001 | 2 | 0.200 |
Why?
|
| Transcription Factors | 1 | 2010 | 1654 | 0.200 |
Why?
|
| Transcription, Genetic | 5 | 2016 | 1157 | 0.190 |
Why?
|
| Nutrition Surveys | 1 | 2001 | 111 | 0.190 |
Why?
|
| Biological Transport | 6 | 2006 | 401 | 0.190 |
Why?
|
| Receptors, Steroid | 2 | 1993 | 42 | 0.180 |
Why?
|
| Health Surveys | 1 | 2001 | 240 | 0.180 |
Why?
|
| Phosphorus, Dietary | 2 | 1997 | 4 | 0.180 |
Why?
|
| Hyperparathyroidism | 6 | 1986 | 67 | 0.170 |
Why?
|
| Alendronate | 5 | 2000 | 13 | 0.170 |
Why?
|
| Computers | 1 | 2000 | 111 | 0.170 |
Why?
|
| Biological Transport, Active | 13 | 1989 | 102 | 0.170 |
Why?
|
| Aged | 18 | 2015 | 19178 | 0.160 |
Why?
|
| RNA, Messenger | 9 | 2010 | 2017 | 0.160 |
Why?
|
| Parathyroid Glands | 7 | 1989 | 74 | 0.160 |
Why?
|
| Promoter Regions, Genetic | 2 | 2013 | 956 | 0.150 |
Why?
|
| Osteomalacia | 4 | 2005 | 13 | 0.150 |
Why?
|
| Diet | 5 | 2005 | 442 | 0.150 |
Why?
|
| Cyclic AMP | 8 | 1992 | 274 | 0.150 |
Why?
|
| Down-Regulation | 3 | 2010 | 520 | 0.140 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 1976 | 0.140 |
Why?
|
| Structure-Activity Relationship | 3 | 2010 | 413 | 0.140 |
Why?
|
| Response Elements | 2 | 2016 | 65 | 0.140 |
Why?
|
| Steroid Hydroxylases | 4 | 2005 | 14 | 0.140 |
Why?
|
| Ileum | 4 | 1986 | 160 | 0.140 |
Why?
|
| Aged, 80 and over | 11 | 2008 | 6817 | 0.140 |
Why?
|
| Acidosis | 4 | 1990 | 55 | 0.130 |
Why?
|
| Mycophenolic Acid | 1 | 2016 | 84 | 0.130 |
Why?
|
| Femoral Fractures | 1 | 2016 | 27 | 0.130 |
Why?
|
| Fractals | 4 | 2006 | 42 | 0.130 |
Why?
|
| Liver | 5 | 2016 | 1208 | 0.130 |
Why?
|
| Intestine, Small | 5 | 1989 | 299 | 0.130 |
Why?
|
| Osteoblasts | 1 | 1995 | 98 | 0.120 |
Why?
|
| Imidazoles | 1 | 2016 | 148 | 0.120 |
Why?
|
| Glucuronosyltransferase | 1 | 2016 | 186 | 0.120 |
Why?
|
| Telomerase | 1 | 2015 | 62 | 0.120 |
Why?
|
| Adult | 29 | 2015 | 26631 | 0.120 |
Why?
|
| Middle Aged | 24 | 2015 | 25995 | 0.120 |
Why?
|
| Dihydroxycholecalciferols | 6 | 1981 | 10 | 0.120 |
Why?
|
| Osteosarcoma | 1 | 1995 | 161 | 0.120 |
Why?
|
| Biophysical Phenomena | 3 | 2000 | 124 | 0.110 |
Why?
|
| Phenylpropionates | 1 | 2013 | 7 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1994 | 108 | 0.110 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 295 | 0.110 |
Why?
|
| Biophysics | 3 | 2000 | 153 | 0.110 |
Why?
|
| Epithelium | 4 | 2006 | 325 | 0.110 |
Why?
|
| Gene Expression | 2 | 2010 | 1310 | 0.110 |
Why?
|
| Intestines | 2 | 1995 | 416 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2003 | 2662 | 0.110 |
Why?
|
| Indans | 1 | 2013 | 35 | 0.110 |
Why?
|
| Postmenopause | 1 | 2013 | 102 | 0.110 |
Why?
|
| Risk | 7 | 2011 | 657 | 0.110 |
Why?
|
| Femur | 3 | 2005 | 112 | 0.110 |
Why?
|
| Bone Neoplasms | 1 | 1995 | 329 | 0.110 |
Why?
|
| Risk Factors | 6 | 2016 | 5497 | 0.100 |
Why?
|
| Kidney Cortex | 1 | 1992 | 34 | 0.100 |
Why?
|
| Sarcoidosis | 2 | 2011 | 72 | 0.100 |
Why?
|
| Chlorothiazide | 2 | 1982 | 5 | 0.100 |
Why?
|
| Azacitidine | 1 | 2013 | 147 | 0.100 |
Why?
|
| Calbindins | 2 | 2004 | 19 | 0.100 |
Why?
|
| ErbB Receptors | 1 | 2015 | 501 | 0.100 |
Why?
|
| S100 Calcium Binding Protein G | 2 | 2004 | 22 | 0.100 |
Why?
|
| Hyperparathyroidism, Secondary | 3 | 2006 | 69 | 0.100 |
Why?
|
| Ligustrum | 1 | 2010 | 1 | 0.090 |
Why?
|
| Chlorthalidone | 2 | 1988 | 18 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 3448 | 0.090 |
Why?
|
| Prevalence | 2 | 2008 | 1243 | 0.090 |
Why?
|
| Ovariectomy | 2 | 2010 | 82 | 0.090 |
Why?
|
| Drugs, Chinese Herbal | 1 | 2010 | 67 | 0.090 |
Why?
|
| E-Box Elements | 1 | 2010 | 5 | 0.090 |
Why?
|
| Snail Family Transcription Factors | 1 | 2010 | 46 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 7 | 1992 | 502 | 0.090 |
Why?
|
| Quinacrine | 1 | 1989 | 14 | 0.090 |
Why?
|
| Acetylation | 1 | 2010 | 132 | 0.090 |
Why?
|
| Alkalosis | 1 | 1989 | 10 | 0.090 |
Why?
|
| Age Factors | 6 | 2016 | 1872 | 0.090 |
Why?
|
| Cell Membrane | 2 | 1992 | 672 | 0.090 |
Why?
|
| Radiography | 3 | 2008 | 809 | 0.090 |
Why?
|
| Radiotherapy | 8 | 1985 | 334 | 0.090 |
Why?
|
| Neoplasms, Radiation-Induced | 6 | 1985 | 109 | 0.080 |
Why?
|
| Fourier Analysis | 2 | 2000 | 126 | 0.080 |
Why?
|
| Parathyroid Diseases | 1 | 1989 | 9 | 0.080 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 850 | 0.080 |
Why?
|
| Magnesium | 11 | 1988 | 178 | 0.080 |
Why?
|
| Protein Binding | 1 | 2013 | 1488 | 0.080 |
Why?
|
| Analysis of Variance | 3 | 2010 | 899 | 0.080 |
Why?
|
| Electrolytes | 5 | 1989 | 52 | 0.080 |
Why?
|
| Trichlormethiazide | 1 | 1988 | 9 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 2014 | 0.080 |
Why?
|
| Plant Extracts | 1 | 2010 | 245 | 0.080 |
Why?
|
| Cost-Benefit Analysis | 2 | 2008 | 462 | 0.080 |
Why?
|
| Cysts | 1 | 1989 | 106 | 0.080 |
Why?
|
| Cholecalciferol | 3 | 2004 | 35 | 0.080 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2008 | 2 | 0.080 |
Why?
|
| Hip | 1 | 2008 | 18 | 0.080 |
Why?
|
| Medication Adherence | 1 | 2009 | 140 | 0.070 |
Why?
|
| Biomechanical Phenomena | 2 | 2000 | 476 | 0.070 |
Why?
|
| Cell Line | 2 | 2010 | 2496 | 0.070 |
Why?
|
| Hyperthyroidism | 1 | 2008 | 75 | 0.070 |
Why?
|
| Uric Acid | 4 | 1980 | 136 | 0.070 |
Why?
|
| Enzyme Activation | 3 | 1993 | 698 | 0.070 |
Why?
|
| Ion Channels | 2 | 1986 | 246 | 0.070 |
Why?
|
| Calcitonin | 2 | 2000 | 38 | 0.070 |
Why?
|
| Mannitol | 5 | 1986 | 50 | 0.070 |
Why?
|
| Thyroid Neoplasms | 8 | 1985 | 426 | 0.070 |
Why?
|
| Calcaneus | 1 | 2006 | 34 | 0.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 1121 | 0.070 |
Why?
|
| Health Care Costs | 1 | 2008 | 235 | 0.070 |
Why?
|
| Kidney Tubules | 5 | 1995 | 92 | 0.070 |
Why?
|
| Diabetes Complications | 1 | 2007 | 170 | 0.060 |
Why?
|
| Reference Values | 4 | 1998 | 661 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2014 | 2305 | 0.060 |
Why?
|
| Parathyroid Neoplasms | 3 | 1985 | 57 | 0.060 |
Why?
|
| Milk | 1 | 2005 | 53 | 0.060 |
Why?
|
| Kinetics | 5 | 1992 | 1528 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 1985 | 121 | 0.060 |
Why?
|
| Deficiency Diseases | 2 | 2003 | 12 | 0.060 |
Why?
|
| Osteitis Fibrosa Cystica | 2 | 1980 | 4 | 0.060 |
Why?
|
| Area Under Curve | 1 | 2005 | 337 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 1150 | 0.060 |
Why?
|
| Lactose | 1 | 1984 | 27 | 0.060 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 360 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 1985 | 115 | 0.060 |
Why?
|
| Up-Regulation | 2 | 1998 | 727 | 0.060 |
Why?
|
| Cortisone | 2 | 1973 | 9 | 0.060 |
Why?
|
| Teriparatide | 2 | 1994 | 3 | 0.060 |
Why?
|
| Recombinant Proteins | 2 | 1997 | 1012 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 2003 | 51 | 0.060 |
Why?
|
| Ethacrynic Acid | 1 | 1983 | 2 | 0.050 |
Why?
|
| Trifluoperazine | 1 | 1983 | 10 | 0.050 |
Why?
|
| Hip Joint | 3 | 2014 | 54 | 0.050 |
Why?
|
| Calculi | 1 | 1983 | 5 | 0.050 |
Why?
|
| Colforsin | 2 | 1995 | 74 | 0.050 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 293 | 0.050 |
Why?
|
| Ouabain | 1 | 1983 | 24 | 0.050 |
Why?
|
| Radioligand Assay | 2 | 1995 | 32 | 0.050 |
Why?
|
| Allopurinol | 2 | 1980 | 77 | 0.050 |
Why?
|
| Bone Resorption | 2 | 2000 | 42 | 0.050 |
Why?
|
| Carrier Proteins | 1 | 1986 | 681 | 0.050 |
Why?
|
| Blotting, Western | 2 | 1995 | 794 | 0.050 |
Why?
|
| Malates | 1 | 2001 | 5 | 0.050 |
Why?
|
| Ammonium Chloride | 4 | 1989 | 21 | 0.050 |
Why?
|
| Fumarates | 1 | 2001 | 19 | 0.050 |
Why?
|
| Protein Kinases | 2 | 1993 | 213 | 0.050 |
Why?
|
| National Health Programs | 1 | 2001 | 19 | 0.050 |
Why?
|
| Observer Variation | 1 | 2003 | 610 | 0.050 |
Why?
|
| Somatostatin | 1 | 1981 | 53 | 0.050 |
Why?
|
| Lactic Acid | 1 | 2001 | 92 | 0.050 |
Why?
|
| Mice, Knockout | 1 | 2006 | 2002 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2006 | 1242 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 3 | 2000 | 270 | 0.050 |
Why?
|
| Logistic Models | 1 | 2005 | 1213 | 0.050 |
Why?
|
| Glucocorticoids | 3 | 2011 | 358 | 0.050 |
Why?
|
| Adenoma | 2 | 1980 | 247 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 1995 | 293 | 0.040 |
Why?
|
| Cytosol | 2 | 1992 | 193 | 0.040 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2000 | 2 | 0.040 |
Why?
|
| Cross-Sectional Studies | 2 | 2006 | 1714 | 0.040 |
Why?
|
| Magnesium Compounds | 1 | 1980 | 7 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2000 | 154 | 0.040 |
Why?
|
| Calcimycin | 2 | 1992 | 33 | 0.040 |
Why?
|
| Bone Development | 1 | 2000 | 37 | 0.040 |
Why?
|
| Sodium | 4 | 1993 | 331 | 0.040 |
Why?
|
| Tensile Strength | 1 | 1999 | 80 | 0.040 |
Why?
|
| Estrogens | 3 | 2006 | 201 | 0.040 |
Why?
|
| Joint Diseases | 1 | 1999 | 48 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2003 | 599 | 0.040 |
Why?
|
| Surveys and Questionnaires | 2 | 2005 | 2633 | 0.040 |
Why?
|
| Stress, Mechanical | 1 | 2000 | 253 | 0.040 |
Why?
|
| Time Factors | 8 | 2013 | 5340 | 0.040 |
Why?
|
| Dactinomycin | 1 | 1998 | 36 | 0.040 |
Why?
|
| Cycloheximide | 1 | 1998 | 56 | 0.040 |
Why?
|
| Testosterone | 1 | 2000 | 276 | 0.040 |
Why?
|
| Injections, Intraperitoneal | 1 | 1998 | 101 | 0.040 |
Why?
|
| Bicarbonates | 2 | 1989 | 58 | 0.040 |
Why?
|
| Malabsorption Syndromes | 3 | 1985 | 21 | 0.040 |
Why?
|
| Algorithms | 3 | 2014 | 1877 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 1999 | 1942 | 0.040 |
Why?
|
| United States | 4 | 2008 | 6999 | 0.040 |
Why?
|
| Probability | 2 | 2008 | 353 | 0.040 |
Why?
|
| Child | 11 | 1998 | 7175 | 0.040 |
Why?
|
| Phantoms, Imaging | 1 | 1999 | 448 | 0.040 |
Why?
|
| Carbon Dioxide | 2 | 1989 | 201 | 0.040 |
Why?
|
| Mice | 3 | 2006 | 11766 | 0.030 |
Why?
|
| Models, Theoretical | 1 | 1999 | 491 | 0.030 |
Why?
|
| Glucuronides | 1 | 2016 | 34 | 0.030 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2000 | 469 | 0.030 |
Why?
|
| Absorption | 3 | 1985 | 25 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2016 | 123 | 0.030 |
Why?
|
| Osteitis Deformans | 1 | 1996 | 2 | 0.030 |
Why?
|
| Etidronic Acid | 1 | 1996 | 5 | 0.030 |
Why?
|
| Luciferases | 1 | 2016 | 128 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 155 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 136 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2000 | 837 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 1989 | 2364 | 0.030 |
Why?
|
| Spine | 2 | 1995 | 102 | 0.030 |
Why?
|
| Phorbol Esters | 1 | 1995 | 22 | 0.030 |
Why?
|
| Cholestanetriol 26-Monooxygenase | 2 | 1994 | 7 | 0.030 |
Why?
|
| DNA Probes | 1 | 1995 | 77 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1995 | 315 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2007 | 2415 | 0.030 |
Why?
|
| Advisory Committees | 1 | 2016 | 89 | 0.030 |
Why?
|
| Rectum | 1 | 2016 | 148 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2016 | 646 | 0.030 |
Why?
|
| Sex Factors | 3 | 2016 | 1068 | 0.030 |
Why?
|
| Adenylyl Cyclases | 1 | 1995 | 100 | 0.030 |
Why?
|
| Alkaline Phosphatase | 3 | 2000 | 132 | 0.030 |
Why?
|
| Genes, Recessive | 1 | 1995 | 87 | 0.030 |
Why?
|
| Carrier State | 1 | 1995 | 39 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 258 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 1998 | 866 | 0.030 |
Why?
|
| Ion Transport | 1 | 1994 | 81 | 0.030 |
Why?
|
| Telomere | 1 | 2015 | 114 | 0.030 |
Why?
|
| Random Allocation | 1 | 1995 | 327 | 0.030 |
Why?
|
| X Chromosome | 1 | 1995 | 153 | 0.030 |
Why?
|
| Diagnosis, Computer-Assisted | 2 | 1994 | 333 | 0.030 |
Why?
|
| Spleen | 1 | 1995 | 433 | 0.030 |
Why?
|
| Procollagen | 1 | 2013 | 8 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1995 | 1057 | 0.030 |
Why?
|
| Ergocalciferols | 2 | 1985 | 38 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2015 | 211 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 1995 | 922 | 0.030 |
Why?
|
| Genetic Linkage | 1 | 1995 | 624 | 0.030 |
Why?
|
| Osteoporotic Fractures | 1 | 2014 | 47 | 0.030 |
Why?
|
| Cell Compartmentation | 1 | 1992 | 69 | 0.030 |
Why?
|
| Demography | 1 | 2013 | 183 | 0.030 |
Why?
|
| Staurosporine | 1 | 1992 | 33 | 0.030 |
Why?
|
| Alkaloids | 1 | 1992 | 46 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1992 | 137 | 0.030 |
Why?
|
| Calcium Phosphates | 1 | 2013 | 77 | 0.030 |
Why?
|
| Oxalates | 2 | 1984 | 48 | 0.030 |
Why?
|
| Radioimmunoassay | 2 | 1990 | 155 | 0.030 |
Why?
|
| Centrifugation, Density Gradient | 2 | 1989 | 112 | 0.030 |
Why?
|
| Neoplasms | 1 | 2007 | 3043 | 0.020 |
Why?
|
| Adolescent | 7 | 1998 | 9268 | 0.020 |
Why?
|
| Macrophages | 1 | 1995 | 572 | 0.020 |
Why?
|
| Base Sequence | 1 | 1995 | 2327 | 0.020 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 1998 | 580 | 0.020 |
Why?
|
| ROC Curve | 1 | 1994 | 780 | 0.020 |
Why?
|
| Rickets | 2 | 1981 | 5 | 0.020 |
Why?
|
| Radionuclide Imaging | 5 | 1982 | 221 | 0.020 |
Why?
|
| Perfusion | 1 | 1992 | 236 | 0.020 |
Why?
|
| Biomarkers | 2 | 2013 | 1767 | 0.020 |
Why?
|
| Granuloma | 1 | 2011 | 65 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 3027 | 0.020 |
Why?
|
| Creatinine | 4 | 1995 | 293 | 0.020 |
Why?
|
| Metyrapone | 1 | 1970 | 3 | 0.020 |
Why?
|
| Benzothiadiazines | 2 | 1980 | 13 | 0.020 |
Why?
|
| Renal Tubular Transport, Inborn Errors | 2 | 1981 | 3 | 0.020 |
Why?
|
| Cushing Syndrome | 1 | 1970 | 24 | 0.020 |
Why?
|
| Sodium Chloride Symporter Inhibitors | 2 | 1980 | 37 | 0.020 |
Why?
|
| Methylamines | 1 | 1989 | 5 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 1970 | 131 | 0.020 |
Why?
|
| Diuretics | 2 | 1980 | 75 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2016 | 2759 | 0.020 |
Why?
|
| Hypoparathyroidism | 2 | 1981 | 24 | 0.020 |
Why?
|
| Calcium Isotopes | 1 | 1989 | 1 | 0.020 |
Why?
|
| Egtazic Acid | 2 | 1986 | 33 | 0.020 |
Why?
|
| Methods | 1 | 1989 | 151 | 0.020 |
Why?
|
| Intracellular Membranes | 1 | 1989 | 117 | 0.020 |
Why?
|
| Chlorides | 1 | 1989 | 103 | 0.020 |
Why?
|
| Partial Pressure | 1 | 1989 | 50 | 0.020 |
Why?
|
| Thyroglobulin | 2 | 1981 | 59 | 0.020 |
Why?
|
| Child, Preschool | 5 | 1998 | 3733 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 887 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1970 | 344 | 0.020 |
Why?
|
| Glycoproteins | 1 | 1989 | 234 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 1989 | 397 | 0.020 |
Why?
|
| Administration, Oral | 2 | 1996 | 682 | 0.020 |
Why?
|
| Models, Economic | 1 | 2008 | 62 | 0.020 |
Why?
|
| Adenocarcinoma | 3 | 1984 | 1198 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 1989 | 370 | 0.020 |
Why?
|
| Age Distribution | 1 | 2008 | 200 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2011 | 430 | 0.020 |
Why?
|
| Muscle, Smooth | 1 | 1989 | 354 | 0.020 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2008 | 143 | 0.020 |
Why?
|
| Mice, Nude | 1 | 1989 | 815 | 0.020 |
Why?
|
| Pedigree | 1 | 1989 | 970 | 0.020 |
Why?
|
| Ruthenium Red | 1 | 1986 | 2 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 2 | 1981 | 414 | 0.020 |
Why?
|
| Barium | 1 | 1986 | 31 | 0.020 |
Why?
|
| Uncoupling Protein 1 | 1 | 1986 | 38 | 0.020 |
Why?
|
| Technetium | 3 | 1982 | 29 | 0.020 |
Why?
|
| Jejunum | 2 | 1985 | 80 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 1986 | 120 | 0.020 |
Why?
|
| Homeostasis | 2 | 1986 | 417 | 0.020 |
Why?
|
| Furosemide | 1 | 1986 | 34 | 0.020 |
Why?
|
| Thyroidectomy | 5 | 1985 | 171 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 2343 | 0.020 |
Why?
|
| Recurrence | 1 | 1989 | 1144 | 0.020 |
Why?
|
| Menopause | 1 | 1986 | 76 | 0.020 |
Why?
|
| Tritium | 3 | 1974 | 133 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 2367 | 0.020 |
Why?
|
| Nitrendipine | 1 | 1985 | 5 | 0.020 |
Why?
|
| Nifedipine | 1 | 1985 | 25 | 0.020 |
Why?
|
| Mitochondrial Proteins | 1 | 1986 | 127 | 0.020 |
Why?
|
| Verapamil | 1 | 1985 | 34 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1986 | 316 | 0.020 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2005 | 6 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2884 | 0.020 |
Why?
|
| Body Weight | 1 | 2006 | 452 | 0.020 |
Why?
|
| Crystallization | 2 | 1989 | 210 | 0.020 |
Why?
|
| Hypocalcemia | 1 | 1985 | 43 | 0.020 |
Why?
|
| Uterus | 1 | 2006 | 222 | 0.020 |
Why?
|
| Ricinoleic Acids | 1 | 1984 | 2 | 0.020 |
Why?
|
| Deoxycholic Acid | 1 | 1984 | 10 | 0.020 |
Why?
|
| Taurocholic Acid | 1 | 1984 | 6 | 0.020 |
Why?
|
| Raffinose | 1 | 1984 | 23 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2005 | 79 | 0.020 |
Why?
|
| Oligosaccharides | 1 | 1984 | 24 | 0.020 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1984 | 28 | 0.020 |
Why?
|
| Serum Albumin | 1 | 1985 | 127 | 0.010 |
Why?
|
| Weight Gain | 1 | 2005 | 119 | 0.010 |
Why?
|
| Carcinoma, Papillary | 2 | 1976 | 160 | 0.010 |
Why?
|
| Minerals | 1 | 1984 | 22 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 1984 | 144 | 0.010 |
Why?
|
| Fetus | 1 | 1985 | 232 | 0.010 |
Why?
|
| Chromatography, Gel | 2 | 1974 | 103 | 0.010 |
Why?
|
| Oxygen | 1 | 1989 | 743 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 4143 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 1985 | 255 | 0.010 |
Why?
|
| Blood Gas Analysis | 3 | 1989 | 38 | 0.010 |
Why?
|
| Neck | 3 | 1978 | 104 | 0.010 |
Why?
|
| Signal Transduction | 1 | 1993 | 3387 | 0.010 |
Why?
|
| Head | 3 | 1978 | 137 | 0.010 |
Why?
|
| Pseudohypoparathyroidism | 1 | 1981 | 5 | 0.010 |
Why?
|
| Salivary Gland Neoplasms | 2 | 1985 | 68 | 0.010 |
Why?
|
| Thyroid Diseases | 1 | 1982 | 105 | 0.010 |
Why?
|
| Nephrotic Syndrome | 1 | 1981 | 33 | 0.010 |
Why?
|
| Hydrogen | 1 | 1981 | 47 | 0.010 |
Why?
|
| Calcifediol | 1 | 1981 | 20 | 0.010 |
Why?
|
| Radiation Injuries | 1 | 1982 | 162 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2008 | 1048 | 0.010 |
Why?
|
| Basal Cell Nevus Syndrome | 1 | 1980 | 4 | 0.010 |
Why?
|
| Struvite | 1 | 1980 | 7 | 0.010 |
Why?
|
| Calcification, Physiologic | 1 | 2000 | 33 | 0.010 |
Why?
|
| Acidosis, Renal Tubular | 1 | 1980 | 11 | 0.010 |
Why?
|
| Penicillamine | 1 | 1980 | 12 | 0.010 |
Why?
|
| Cellulose | 1 | 1980 | 56 | 0.010 |
Why?
|
| Carcinoma, Basal Cell | 1 | 1980 | 62 | 0.010 |
Why?
|
| Cystinuria | 1 | 1980 | 13 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2000 | 45 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2000 | 24 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 2 | 1985 | 1063 | 0.010 |
Why?
|
| Collagen Type I | 1 | 2000 | 72 | 0.010 |
Why?
|
| Administration, Intranasal | 1 | 2000 | 138 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 1980 | 81 | 0.010 |
Why?
|
| Palatine Tonsil | 2 | 1977 | 30 | 0.010 |
Why?
|
| Placebos | 1 | 2000 | 214 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1986 | 1225 | 0.010 |
Why?
|
| Nasopharynx | 2 | 1977 | 50 | 0.010 |
Why?
|
| Purines | 1 | 1980 | 93 | 0.010 |
Why?
|
| Life Style | 1 | 2000 | 172 | 0.010 |
Why?
|
| Hysterectomy | 1 | 2000 | 151 | 0.010 |
Why?
|
| Chronic Kidney Disease-Mineral and Bone Disorder | 1 | 1978 | 23 | 0.010 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 1978 | 28 | 0.010 |
Why?
|
| Dogs | 1 | 2000 | 704 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1998 | 12 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2000 | 231 | 0.010 |
Why?
|
| Collagen | 1 | 2000 | 293 | 0.010 |
Why?
|
| Radius | 1 | 1998 | 31 | 0.010 |
Why?
|
| Glucose | 1 | 1981 | 630 | 0.010 |
Why?
|
| Culture Media | 2 | 1989 | 147 | 0.010 |
Why?
|
| Puberty | 1 | 1998 | 60 | 0.010 |
Why?
|
| Nutritional Status | 1 | 1998 | 80 | 0.010 |
Why?
|
| Hormones | 1 | 1998 | 139 | 0.010 |
Why?
|
| Acute Kidney Injury | 1 | 1981 | 312 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 648 | 0.010 |
Why?
|
| Palpation | 1 | 1976 | 18 | 0.010 |
Why?
|
| Goiter, Nodular | 1 | 1976 | 7 | 0.010 |
Why?
|
| Calcium Carbonate | 1 | 1995 | 3 | 0.010 |
Why?
|
| Respiratory System | 1 | 1976 | 116 | 0.010 |
Why?
|
| Magnesium Deficiency | 1 | 1975 | 5 | 0.010 |
Why?
|
| Body Height | 1 | 1995 | 100 | 0.010 |
Why?
|
| Thymus Gland | 1 | 1976 | 197 | 0.010 |
Why?
|
| Follow-Up Studies | 3 | 1978 | 3667 | 0.010 |
Why?
|
| Amino Acids | 1 | 1996 | 245 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 1976 | 470 | 0.010 |
Why?
|
| Proteinuria | 1 | 1995 | 67 | 0.010 |
Why?
|
| Prospective Studies | 2 | 1998 | 4293 | 0.010 |
Why?
|
| Eye | 1 | 1995 | 111 | 0.010 |
Why?
|
| Epinephrine | 2 | 1985 | 88 | 0.010 |
Why?
|
| Models, Biological | 1 | 1981 | 1766 | 0.010 |
Why?
|
| Hypertension | 1 | 1980 | 746 | 0.010 |
Why?
|
| Chromatography | 1 | 1973 | 28 | 0.010 |
Why?
|
| Pain | 1 | 1996 | 399 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2000 | 2873 | 0.010 |
Why?
|
| Biopsy | 1 | 1996 | 1185 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1998 | 2486 | 0.010 |
Why?
|
| Potassium | 1 | 1993 | 255 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 1995 | 1719 | 0.010 |
Why?
|
| Infant | 1 | 1978 | 3161 | 0.010 |
Why?
|
| Incidence | 1 | 1995 | 1597 | 0.010 |
Why?
|
| Citrates | 1 | 1970 | 28 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 1973 | 600 | 0.010 |
Why?
|
| Poisoning | 1 | 1970 | 42 | 0.010 |
Why?
|
| Chemistry | 1 | 1989 | 54 | 0.010 |
Why?
|
| Chemistry, Physical | 1 | 1989 | 29 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1989 | 72 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1989 | 109 | 0.010 |
Why?
|
| Phenotype | 1 | 1995 | 2443 | 0.000 |
Why?
|
| Thyroid Gland | 2 | 1981 | 280 | 0.000 |
Why?
|
| Osmolar Concentration | 1 | 1986 | 181 | 0.000 |
Why?
|
| Diuresis | 1 | 1986 | 26 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 1999 | 8247 | 0.000 |
Why?
|
| Infusions, Parenteral | 1 | 1985 | 51 | 0.000 |
Why?
|
| Maternal-Fetal Exchange | 1 | 1985 | 77 | 0.000 |
Why?
|
| Sheep | 1 | 1985 | 250 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 1989 | 1800 | 0.000 |
Why?
|
| Plicamycin | 1 | 1984 | 9 | 0.000 |
Why?
|
| Thiourea | 1 | 1984 | 9 | 0.000 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1984 | 26 | 0.000 |
Why?
|
| Oxalic Acid | 1 | 1984 | 8 | 0.000 |
Why?
|
| Permeability | 1 | 1984 | 137 | 0.000 |
Why?
|
| Pancreatitis | 1 | 1984 | 86 | 0.000 |
Why?
|
| Dacarbazine | 1 | 1984 | 102 | 0.000 |
Why?
|
| Blood Chemical Analysis | 1 | 1984 | 41 | 0.000 |
Why?
|
| Chicago | 2 | 1980 | 1427 | 0.000 |
Why?
|
| Urine | 1 | 1984 | 89 | 0.000 |
Why?
|
| Blood | 1 | 1982 | 69 | 0.000 |
Why?
|
| Nephrectomy | 1 | 1985 | 295 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1985 | 950 | 0.000 |
Why?
|
| 25-Hydroxyvitamin D 2 | 1 | 1981 | 5 | 0.000 |
Why?
|
| Hydroxylation | 1 | 1981 | 17 | 0.000 |
Why?
|
| Ligation | 1 | 1981 | 51 | 0.000 |
Why?
|
| Common Bile Duct | 1 | 1981 | 21 | 0.000 |
Why?
|
| Renal Dialysis | 1 | 1984 | 335 | 0.000 |
Why?
|
| Cholestasis | 1 | 1981 | 45 | 0.000 |
Why?
|
| Bile Acids and Salts | 1 | 1981 | 66 | 0.000 |
Why?
|
| Autopsy | 1 | 1980 | 122 | 0.000 |
Why?
|
| Japan | 1 | 1980 | 304 | 0.000 |
Why?
|
| Pregnancy | 1 | 1985 | 3018 | 0.000 |
Why?
|
| Gamma Rays | 1 | 1976 | 73 | 0.000 |
Why?
|
| Technology, Radiologic | 1 | 1976 | 104 | 0.000 |
Why?
|
| X-Rays | 1 | 1975 | 135 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1975 | 403 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1974 | 273 | 0.000 |
Why?
|
| Prognosis | 1 | 1978 | 3787 | 0.000 |
Why?
|